MUC16 and ovarian carcinoma: developed the monoclonal antibody 5E11 against a specific peptide segment FNTTER of ovarian cancer MUC16, which specifically recognizes MUC16, leading to the design of a MUC16-based vaccine to stimulate an immune response (150).